AST-120
- Generic Name
- AST-120
Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis
- First Posted Date
- 2007-12-31
- Last Posted Date
- 2014-06-18
- Lead Sponsor
- Ocera Therapeutics
- Target Recruit Count
- 2
- Registration Number
- NCT00583531
- Locations
- 🇺🇸
Mayo Clinic, Inflammatory Bowel Disease Clinic, Rochester, Minnesota, United States
Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome
- First Posted Date
- 2007-12-31
- Last Posted Date
- 2014-06-18
- Lead Sponsor
- Ocera Therapeutics
- Target Recruit Count
- 117
- Registration Number
- NCT00583128
- Locations
- 🇺🇸
Chevy Chase Clinical Research, Chevy Chase, Maryland, United States
🇺🇸Medical Center for Clinical Research, San Diego, California, United States
🇺🇸Madeleine DuPree, MD, Boynton Beach, Florida, United States
Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2014-05-30
- Lead Sponsor
- Ocera Therapeutics
- Target Recruit Count
- 40
- Registration Number
- NCT00558038
- Locations
- 🇺🇸
University of Massachusetts Medical School, Worchester, Massachusetts, United States
🇺🇸McGuire VA Medical Center, Richmond, Virginia, United States
🇺🇸Mount Sinai School of Medicine, New York, New York, United States
A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)
- First Posted Date
- 2007-07-13
- Last Posted Date
- 2022-06-07
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 1015
- Registration Number
- NCT00501046
A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)
- First Posted Date
- 2007-07-13
- Last Posted Date
- 2022-06-07
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 1020
- Registration Number
- NCT00500682
Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease
- Conditions
- Kidney Failure, Chronic
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2007-10-18
- Lead Sponsor
- Institute for Health Outcomes and Process Evaluation Reseach
- Target Recruit Count
- 450
- Registration Number
- NCT00456859
- Locations
- 🇯🇵
iHope International, Tokyo, Japan
Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2014-05-30
- Lead Sponsor
- Ocera Therapeutics
- Target Recruit Count
- 191
- Registration Number
- NCT00321412
- Locations
- 🇦🇹
Universitatsklinik fur Innere Medizin I der PMU, Salzburg, Austria
🇧🇪University Hospital Gasthuisberg, University of Leuven, Leuven, Belgium
🇺🇸University of North Carolina, Chapel Hill, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.